A Case of Balsalazide-Induced Limited Form of Granulomatosis with Polyangiitis with Bronchiolitis Obliterans Organizing Pneumonia-like Variant in Ulcerative Colitis |
Kang, Shin-Myung
(Department of Pulmonary and Critical Care Medicine, Gachon University Gil Hospital)
Jang, Young-Rock (Department of Pulmonary and Critical Care Medicine, Gachon University Gil Hospital) Yoon, Hyun-Hwa (Department of Pulmonary and Critical Care Medicine, Gachon University Gil Hospital) Kim, Su-Ji (Department of Pulmonary and Critical Care Medicine, Gachon University Gil Hospital) Kim, Eun-Young (Department of Radiology, Gachon University Gil Hospital) Ha, Seung-Yeon (Department of Pathology, Gachon University Gil Hospital) Park, Jeong-Woong (Department of Pulmonary and Critical Care Medicine, Gachon University Gil Hospital) |
1 | Muzzi A, Ciani F, Bianchini D, Festini G, Volpe C. Adverse pulmonary effects of mesalamine. Chest 1995; 108:1181. |
2 | Park JE, Hwangbo Y, Chang R, Chang YW, Jang JY, Kim BH, et al. Mesalazine-induced eosinophilic pneumonia in a patient with Crohn's disease. Korean J Gastroenterol 2009;53:116-20. |
3 | Tanigawa K, Sugiyama K, Matsuyama H, Nakao H, Kohno K, Komuro Y, et al. Mesalazine-induced eosinophilic pneumonia. Respiration 1999;66:69-72. |
4 | Bitton A, Peppercorn MA, Hanrahan JP, Upton MP. Mesalamine-induced lung toxicity. Am J Gastroenterol 1996;91:1039-40. |
5 | Foster RA, Zander DS, Mergo PJ, Valentine JF. Mesalamine- related lung disease: clinical, radiographic, and pathologic manifestations. Inflamm Bowel Dis 2003;9: 308-15. |
6 | Camus P, Piard F, Ashcroft T, Gal AA, Colby TV. The lung in inflammatory bowel disease. Medicine (Baltimore) 1993;72:151-83. |
7 | Yano S, Kobayashi K, Kato K, Nishimura K. A limited form of Wegener's granulomatosis with bronchiolitis obliterans organizing pneumonitis-like variant in an ulcerative colitis patient. Intern Med 2002;41:1013-5. |
8 | Kasuga A, Mandai Y, Katsuno T, Sato T, Yamaguchi T, Yokosuka O. Pulmonary complications resembling Wegener's granulomatosis in ulcerative colitis with elevated proteinase-3 anti-neutrophil cytoplasmic antibody. Intern Med 2008;47:1211-4. |
9 | Salerno SM, Ormseth EJ, Roth BJ, Meyer CA, Christensen ED, Dillard TA. Sulfasalazine pulmonary toxicity in ulcerative colitis mimicking clinical features of Wegener's granulomatosis. Chest 1996;110:556-9. |
10 | Stebbing J, Askin F, Fishman E, Stone J. Pulmonary manifestations of ulcerative colitis mimicking Wegener's granulomatosis. J Rheumatol 1999;26:1617-21. |
11 | Meyer KC, Raghu G. Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Eur Respir J 2011;38:761-9. |
12 | Wiggins JB, Rajapakse R. Balsalazide: a novel 5-aminosalicylate prodrug for the treatment of active ulcerative colitis. Expert Opin Drug Metab Toxicol 2009;5:1279-84. |
13 | Tursi A. Balsalazide in treating colonic diseases. Expert Opin Drug Metab Toxicol 2009;5:1555-63. |
14 | Khan A, Lawson CA, Quinn MA, Isdale AH, Green MJ. Successful treatment of ANCA-negative Wegener's granulomatosis with rituximab. Int J Rheumatol 2010; 2010:846063. |